A series of novel N-phenylbenzamide and N-phenylacetophenone compounds were synthesized and evaluated for their antiviral activity against HCV and EV71(strain SZ-98).The biological results showed that three compounds(...A series of novel N-phenylbenzamide and N-phenylacetophenone compounds were synthesized and evaluated for their antiviral activity against HCV and EV71(strain SZ-98).The biological results showed that three compounds(23,25 and 41) exhibited considerable anti-HCV activity(IC50? 0.57–7.12 μmol/L) and several compounds(23,28,29,30,31 and 42) displayed potent activity against EV71 with the IC50 values lower than 5.00 μmol/L.The potency of compound 23(IC50? 0.57 μmol/L) was superior to that of reported compounds IMB-1f(IC50? 1.90 μmol/L) and IMB-1g(IC50? 1.00 μmol/L) as anti-HCV agents,and compound29 possessed the highest anti-EV71 activity,comparable to the comparator drug pirodavir.The efficacy in vivo and antiviral mechanism of these compounds warrant further investigations.展开更多
肠道病毒71型(enterovirus 71,EV71)是引起手足口病(hand,foot and mouth disease,HFMD)的主要病原体之一,严重威胁婴幼儿健康并在亚太地区引发重大传染性疾病。宿主固有免疫应答是抗病毒感染最有效的方式,然而EV71在和宿主相互博弈的...肠道病毒71型(enterovirus 71,EV71)是引起手足口病(hand,foot and mouth disease,HFMD)的主要病原体之一,严重威胁婴幼儿健康并在亚太地区引发重大传染性疾病。宿主固有免疫应答是抗病毒感染最有效的方式,然而EV71在和宿主相互博弈的过程中,进化出一系列机制逃逸固有免疫监视并破坏其抗病毒功能。本文主要围绕EV71的固有免疫逃逸机制研究进展进行综述,旨在为抗EV71感染药物的研发提供帮助。展开更多
基金supported by the National Natural Science Foundation of China (Nos.81273439 and 81202414)Student Fund of Innovation Project of Peking Union Medical College (No.2013-1007-10)
文摘A series of novel N-phenylbenzamide and N-phenylacetophenone compounds were synthesized and evaluated for their antiviral activity against HCV and EV71(strain SZ-98).The biological results showed that three compounds(23,25 and 41) exhibited considerable anti-HCV activity(IC50? 0.57–7.12 μmol/L) and several compounds(23,28,29,30,31 and 42) displayed potent activity against EV71 with the IC50 values lower than 5.00 μmol/L.The potency of compound 23(IC50? 0.57 μmol/L) was superior to that of reported compounds IMB-1f(IC50? 1.90 μmol/L) and IMB-1g(IC50? 1.00 μmol/L) as anti-HCV agents,and compound29 possessed the highest anti-EV71 activity,comparable to the comparator drug pirodavir.The efficacy in vivo and antiviral mechanism of these compounds warrant further investigations.
文摘肠道病毒71型(enterovirus 71,EV71)是引起手足口病(hand,foot and mouth disease,HFMD)的主要病原体之一,严重威胁婴幼儿健康并在亚太地区引发重大传染性疾病。宿主固有免疫应答是抗病毒感染最有效的方式,然而EV71在和宿主相互博弈的过程中,进化出一系列机制逃逸固有免疫监视并破坏其抗病毒功能。本文主要围绕EV71的固有免疫逃逸机制研究进展进行综述,旨在为抗EV71感染药物的研发提供帮助。
